×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [26]
内容类型
期刊论文 [25]
会议论文 [1]
发表日期
2019 [6]
2018 [3]
2017 [6]
2016 [1]
2015 [6]
2014 [2]
更多...
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共26条,第1-10条
帮助
限定条件
专题:中国医学科学院 北京协和医学院
第一署名单位
第一作者单位
通讯作者单位
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Second-generation EGFR and ErbB tyrosine kinase inhibitors as first-line treatments for non-small cell lung cancer
期刊论文
2019, 卷号: 12, 页码: 6535-6548
作者:
Wang, Shouzheng
;
Li, Junling
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2020/01/03
afatinib
dacomitinib
epidermal growth factor receptor
non-small-cell lung cancer
Comparative review of drug-drug interactions with epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer
期刊论文
2019, 卷号: 12, 页码: 5467-5484
作者:
Xu, Zi-Yi
;
Li, Jun-Ling
收藏
  |  
浏览/下载:7/0
  |  
提交时间:2020/01/03
drug metabolism
pharmacokinetics
CYP450
UDP-glucuronosyltransferase
P-glycoprotein
China National Medical Products Administration approval summary: anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy
期刊论文
2019, 卷号: 39, 期号: 1, 页码: 36
作者:
Zhou, Ming
;
Chen, Xiaoyuan
;
Zhang, Hong
;
Xia, Lin
;
Tong, Xin
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2020/01/03
Advanced non-small cell lung cancer
Anlotinib
Anti-angiogenesis
Epidermal growth factor receptor
Activating anaplastic lymphoma kinase
Adverse drug reaction
National Medical Products Administration
Circular RNA profiling identified as a biomarker for predicting the efficacy of Gefitinib therapy or non-small cell lung cancer
期刊论文
2019, 卷号: 11, 期号: 5, 页码: 1779-+
作者:
Liu, Yu-Tao
;
Han, Xiao-Hong
;
Xing, Pu-Yuan
;
Hu, King-Sheng
;
Hao, Xue-Zhi
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Non-small cell lung cancer (NSCLC)
circular RNA (circRNA)
epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI)
predictive biomarker
Antitumor activity of histone deacetylase inhibitor chidamide alone or in combination with epidermal growth factor receptor tyrosine kinase inhibitor icotinib in NSCLC
期刊论文
2019, 卷号: 10, 期号: 5, 页码: 1275-1287
作者:
Zhang, Ningning
;
Liang, Caixia
;
Song, Wenya
;
Tao, Dan
;
Yao, Jiarui
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2020/01/03
Concurrent Driver Gene Mutations as Negative Predictive Factors in Epidermal Growth Factor Receptor-Positive Non-Small Cell Lung Cancer
期刊论文
2019, 卷号: 42, 页码: 304-310
作者:
Chen, Minjiang
;
Xu, Yan
;
Zhao, Jing
;
Zhong, Wei
;
Zhang, Li
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
Non-small cell lung cancer
Epidermal growth factor receptor tyrosine kinase inhibitor
Predictive factor
Co-occurring mutations
The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs
期刊论文
2018, 卷号: 97, 期号: 30, 页码: e11648
作者:
Zhang, Yuan
;
Feng, Yang-Chun
;
Zhu, Hong-Ge
;
Xiong, Ting-Chuan
;
Hou, Yan-Shen
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
epidermal growth factor receptor
lymphocyte-to-monocyte ratio
neutrophil-to-lymphocyte ratio
nonsmall cell lung cancer
tyrosine kinase inhibitors
Immunotherapy combined with epidermal growth factor receptor-tyrosine kinase inhibitors in non-small-cell lung cancer treatment
期刊论文
2018, 卷号: 11, 页码: 6189-6196
作者:
Liang, Hongge
;
Liu, Xiaoyan
;
Wang, Mengzhao
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2020/01/03
non-small cell lung cancer
epidermal growth factor receptor-tyrosine kinase inhibitors
immunotherapy
Real-world EGFR testing in patients with stage IIIB/IV non-small-cell lung cancer in North China: A multicenter, non-interventional study
期刊论文
2018, 卷号: 9, 期号: 11, 页码: 1461-1469
作者:
Cheng, Ying
;
Wang, Yan
;
Zhao, Jun
;
Liu, Yunpeng
;
Gao, Hongjun
收藏
  |  
浏览/下载:9/0
  |  
提交时间:2020/01/03
Clinical practice
epidermal growth factor receptor
mutation
non-small-cell lung cancer
tyrosine kinase inhibitor
Potential Resistance Mechanisms Revealed by Targeted Sequencing from Lung Adenocarcinoma Patients with Primary Resistance to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors (TKIs)
期刊论文
2017, 卷号: 12, 期号: 12, 页码: 1766-1778
作者:
Zhong, Jia
;
Li, Lei
;
Wang, Zhijie
;
Bai, Hua
;
Gai, Fei
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2020/01/03
Lung adenocarcinoma
EGFR TKIs
NGS
Primary resistance
©版权所有 ©2017 CSpace - Powered by
CSpace